College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP Calendar of Events > Webinars

Featured Sessions

Upcoming Sessions   Previous Sessions  
Member Meeting Calendar
Membership login required

   LOG IN >


Relieve Anxiety: Get the Truth About MOC From the ABP CEO
(Session 2 - The MOC Exam)

This webinar addresses questions and fears pathologists have about the Maintenance of Certification process.

Presented by Rebecca L. Johnson, MD, FCAP, Chief Executive Officer, American Board of Pathology (ABP) and Chad R. Rund, DO, FCAP, Chair, New in Practice Committee, this webinar series will provide accurate information on the ABP MOC program and ease anxiety around the testing process. Session 2 will provide the opportunity to ask Dr. Johnson questions about what to expect on the exam.

Learning Objectives:

 • Provide an overview of what is required for MOC Part III
 • Gain a better understanding of what the test will entail—
    difficulty level, format, cost, etc.
 • Address concerns related to failure of exam including
    retakes and appeals process
 • Understand the recertification requirements by subspecialty
 • Opportunity to ask the ABP Chief Executive Officer questions

Rebecca L. Johnson, MD, FCAP, Chief Executive Officer,
American Board of Pathology (ABP)
Chad R. Rund, DO, FCAP, Chair, New in Practice Committee

Nov. 4, 2014
12-1 PM CT

Register Now

Breast Predictive Factors:
Resolving Test Interpretation Challenges

This interactive case-based webinar worth 1.5 CME, will answer your common questions and challenges related to HER2 and ER/PgR testing. Two of the ASCO/CAP Guideline authors will facilitate a tumor board-like experience where participants weigh-in on real patient cases. This is a unique opportunity to come together and learn from the experts and other pathologists doing breast predictive factors testing.

As a result of participating in this education activity, you will be able to:

 • Accurately interpret HER2 tests as positive, negative or equivocal
    according to the ASCO/CAP HER2 Guideline criteria.
 • Evaluate and integrate HER2 test results with clinical
    and morphologic findings.
 • Determine appropriate next steps when a HER2 test result
    is discordant with the patient’s profile or other HER2 tests.
 • Apply the ASCO/CAP Guideline criteria for reporting
    HER2 test results.
 • Provide appropriate resolution and clarification in reports
    when HER2 results are equivocal, indeterminate,
    or complex (eg, intratumoral heterogeneity
    or chromosome 17 aneusomy).

Dr. M. Elizabeth Hammond
Dr. David Hicks

Nov. 6, 2014
12-1:30 PM CT

Register Now

Practical Genomics for the Practicing Pathologist Webinar Series – Selecting the Right Tissue for Genomic Oncology Testing

This CME webinar will specify the criteria for determining if cells of diagnostic interest are present in a specimen in sufficient quantities for oncology genomic testing. It will include information on developing a quality management program to ensure appropriate specimen collection through slide review and techniques for providing feedback to clinicians regarding specimen quality.


    1. Assess and document tumor cell percent.
    2. Describe the impact of overestimating or underestimating
        tumor cell percentage with regard to molecular testing.
    3. Identify tissue suitable for genomic testing.

Dr. Sophia Yohe, MD, FCAP

Nov. 20, 2014
12:00 PM - 1:00PM CT

Register Now


Gene Sets for Cancer NGS Testing: What's Available

Next-generation sequencing (NGS) for cancer is offered by commercial for-profit laboratories, independent laboratory networks, and laboratories in academic medical centers and integrated health networks. Currently, laboratories offering clinical NGS offer varying gene sets, either custom-designed or based on a vendor offering. Some cancer gene sets are organ-specific (e.g., so-called lung cancer panels), while others include genes significant in different cancers (so-called pan-cancer panels). The variability among the tests has created a complex, confusing environment.

In this webinar, the speakers will discuss commonalities and differences between NGS tests available for cancer testing today.

This presentation will also discuss the Cancer Genomics Resource List, developed in 2014 to assist the pathology and clinical oncology communities. This list is a compilation of over 500 genes included in current NGS-based cancer tests. Many of these genes were annotated with their applicability to diagnosis, prognosis or therapeutic action based on published knowledge, including public databases and the medical literature. The Cancer Genomics Resource List can provide pathologists with a starting point for the development or selection of NGS cancer panels.

Objectives of this presentation:
 • Describe the genes included in NGS cancer tests today.
 • Compare and contrast the NGS cancer tests in current clinical use.
 • Describe the format and content of the Cancer Genomics Resource List 2014.

Presenters: Mary M. Zutter, MD, FCAP, and Ian S. Hagemann, MD, PhD, FCAP

Dec. 4, 2014
10:30-11:30 AM CT

Register Now

Security of Patient Data:
Handling Protected Health Information in the Lab

Not being aware of your responsibilities as a pathologist using protected electronic health information can lead to the inadvertent disclosure of that information. Further, if your institution's systems and policies are not compliant with federal legislation and regulations, then it may be as risk for penalties. This interactive, CME webinar will address security and privacy requirements for managing patient data, as well as important compliance considerations.

 • Identify federal legislation relevant to patient data storage,
    access control, and transmission.
 • Discuss options for secure storage and transport of information.
 • Describe laboratory policies for personnel to use data and maintain
    compliance with regulatory requirements.

Dr. Myra Wilkerson, MD, FCAP

Dec. 10, 2014
12 PM-1 PM CT

Register Now

Practical Genomics for the Practicing Pathologist Webinar Series-Cancer Genomics: Pathologists Adding Value as a Molecular Consultant

The pathologist has an important and burgeoning role in helping to order the right genomic test that will inform diagnostic, prognostic, and/or therapeutic decision-making. This interactive, CME webinar will address genomic test selection and interpretation, as well as how to educate and guide others as a molecular consultant. In addition, the webinar will prepare you to contribute and apply cancer genomic information in new ways to add value to the healthcare system.


 1. Identify criteria for selecting high-value molecular tests.
 2. Guide appropriate molecular test utilization.
 3. Interpret the diagnostic, prognostic, and therapeutic significance of
    genomic test results.
 4. Identify opportunities to educate healthcare providers on the
    significance and value of genomic testing.

Dr. Pranil Chandra, DO, FCAP

Dec. 11, 2014
12-1 PM CT

Register Now

Integrated Disease Reporting: Order from (almost) Chaos

As the complexity of the data used to manage patients with chronic diseases such as cancer has grown, the task of the clinician has become increasingly difficult and time consuming. At worst, patient safety can be compromised or delivery of care delayed due to the difficulty in retrieving all of the necessary data elements needed for treatment. The need to retrieve test results from different departmental information systems such as the laboratory information system (LIS), the radiology picture archiving and communication system (PACS), different areas of the electronic medical record (EMR), and from systems external to the treating facility or hospital system, contribute to this situation. We outline a framework that takes advantages of the capabilities of electronic reporting to create an Integrated Disease Report (IDR) - a single, succinct, integrated, interpretive report comprising all data pertinent to the disease: pathology results, laboratory data, imaging correlations, risk profiles, and therapeutic implications. This is a free, non-CME webinar.

Monica E. de Baca, MD
Director of Hematopathology, Hematologics Inc.
CAP Diagnostic Intelligence and Health IT (DIHIT) Committee member
Co-chair for the DIHIT Integrated Reporting Workgroup

George Birdsong, MD
Department of Pathology and Laboratory Medicine
Emory University School of Medicine/Grady Health System, Atlanta, GA
CAP Diagnostic Intelligence and Health IT (DIHIT) Committee member
Co-chair for the DIHIT Integrated Reporting Workgroup

Dec. 16, 2014
1-2 PM CT

Register Now
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed